When Canaccord Genuity’s Matt Bottomley recently increased his price target for a marijuana stock, the markets listened.
As the Alternative Pharmaceuticals Research Analyst at Canaccord, Bottomley is quickly becoming a market mover in the cannabis space. Ranked #122 out of 4,749 financial analysts on TipRanks, Bottomley has delivered an 87% success rate on his recommendations.
Matt Bottomley’s Qualifications
Before investors start following an analyst’s recomendations, it’s important to look into their qualifications. While analysts oftentimes have similar credentials, they aren’t all created equal.
Educated at McMaster University in Ontario, Matt Bottomley is a CPA, CFE, CBV, and CFF. For those who aren’t familiar with all of these designations, that means that Matt Bottomley is a Chartered Professional Accountant, a Certified Fraud Examiner, a Chartered Business Valuator, and last but not least Certified in Financial Forensics. Beyond that, he has also completed his CFA Level I and CFA Level II.
With all of these specializations and professional designations, it’s no wonder he’s so accurate!
Matt Bottomley’s Cannabis Coverage
Given his accuracy, we wanted to give cannabis investors a list of all the pot stocks Bottomley covers. According to Canaccord’s website, Bottomley is currently covering five different cannabis companies:
Always be sure to do your own due diligence on a company before following an analyst’s recommendation. Also, remember that an analyst’s recommendation is not tailored to any specific investor, and therefore a ‘buy’ rating doesn’t necessarily mean that you should buy. Always consult your trusted professional financial advisor before making an investment decision.
Get Real-Time Updates from The Daily Marijuana Observer